BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 20196967)

  • 21. The role of fish oil in arrhythmia prevention.
    Anand RG; Alkadri M; Lavie CJ; Milani RV
    J Cardiopulm Rehabil Prev; 2008; 28(2):92-8. PubMed ID: 18360184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of sudden cardiac death by n-3 polyunsaturated fatty acids.
    Leaf A
    Fundam Clin Pharmacol; 2006 Dec; 20(6):525-38. PubMed ID: 17109646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. n-3 PUFAs and cardiovascular disease prevention.
    Manerba A; Vizzardi E; Metra M; Dei Cas L
    Future Cardiol; 2010 May; 6(3):343-50. PubMed ID: 20462340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications.
    Bays HE; Tighe AP; Sadovsky R; Davidson MH
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):391-409. PubMed ID: 18327998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How relevant is the ratio of dietary n-6 to n-3 polyunsaturated fatty acids to cardiovascular disease risk? Evidence from the OPTILIP study.
    Griffin BA
    Curr Opin Lipidol; 2008 Feb; 19(1):57-62. PubMed ID: 18196988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: a meta-analysis of randomized controlled trials.
    Zhao YT; Chen Q; Sun YX; Li XB; Zhang P; Xu Y; Guo JH
    Ann Med; 2009; 41(4):301-10. PubMed ID: 19148838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fish oil and heart health.
    de Leiris J; de Lorgeril M; Boucher F
    J Cardiovasc Pharmacol; 2009 Nov; 54(5):378-384. PubMed ID: 19568180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of omega-3 fatty acids and the prevention of coronary heart disease.
    Harper CR; Jacobson TA
    Am J Cardiol; 2005 Dec; 96(11):1521-9. PubMed ID: 16310434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Omega-3 polyunsaturated fatty acids and cardiovascular diseases].
    Marchioli R
    Minerva Cardioangiol; 2003 Oct; 51(5):561-76. PubMed ID: 14551524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rationale and design of a randomised controlled clinical trial on supplemental intake of n-3 fatty acids and incidence of cardiac arrhythmia: SOFA.
    Brouwer IA; Zock PL; Wever EF; Hauer RN; Camm AJ; Böcker D; Otto-Terlouw P; Katan MB; Schouten EG
    Eur J Clin Nutr; 2003 Oct; 57(10):1323-30. PubMed ID: 14506496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for a protective (synergistic?) effect of B-vitamins and omega-3 fatty acids on cardiovascular diseases.
    de Bree A; Mennen LI; Hercberg S; Galan P
    Eur J Clin Nutr; 2004 May; 58(5):732-44. PubMed ID: 15116076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Fish fatty acids and cardiovascular diseases--an update].
    Brouwer IA; Katan MB
    Ned Tijdschr Geneeskd; 2008 Sep; 152(37):2009-14. PubMed ID: 18825888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Docosahexaenoic acid (DHA) and cardiovascular disease risk factors.
    Holub BJ
    Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):199-204. PubMed ID: 19545988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular benefits of omega-3 fatty acids.
    von Schacky C; Harris WS
    Cardiovasc Res; 2007 Jan; 73(2):310-5. PubMed ID: 16979604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of cardiovascular diseases and highly concentrated n-3 polyunsaturated fatty acids (PUFAs).
    Weber HS; Selimi D; Huber G
    Herz; 2006 Dec; 31 Suppl 3():24-30. PubMed ID: 17575803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. n-3 fatty acids and the risk of sudden cardiac death. Emphasis on heart rate variability.
    Christensen JH
    Dan Med Bull; 2003 Nov; 50(4):347-67. PubMed ID: 14694851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-chain omega-3 fatty acids from fish reduce sudden cardiac death in patients with coronary heart disease.
    Richter WO
    Eur J Med Res; 2003 Aug; 8(8):332-6. PubMed ID: 12915328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Omega-3 polyunsaturated fatty acids and human health outcomes.
    Calder PC; Yaqoob P
    Biofactors; 2009; 35(3):266-72. PubMed ID: 19391122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Background and rationale of the SU.FOL.OM3 study: double-blind randomized placebo-controlled secondary prevention trial to test the impact of supplementation with folate, vitamin B6 and B12 and/or omega-3 fatty acids on the prevention of recurrent ischemic events in subjects with atherosclerosis in the coronary or cerebral arteries.
    Galan P; de Bree A; Mennen L; Potier de Courcy G; Preziozi P; Bertrais S; Castetbon K; Hercberg S
    J Nutr Health Aging; 2003; 7(6):428-35. PubMed ID: 14625623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The therapeutic potential of long-chain omega-3 fatty acids in nonalcoholic fatty liver disease.
    Shapiro H; Tehilla M; Attal-Singer J; Bruck R; Luzzatti R; Singer P
    Clin Nutr; 2011 Feb; 30(1):6-19. PubMed ID: 20619513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.